The Real Costs of the New Alzheimer’s Drug, Most of Which Will Fall to Taxpayers
(By Arthur Allen for KFF Health News) The first drug purporting to slow the advance of Alzheimer’s disease is likely
Read More(By Arthur Allen for KFF Health News) The first drug purporting to slow the advance of Alzheimer’s disease is likely
Read More(By Rylee Wilson for Becker’s Hospital Review) CMS is projecting Medicare Part D premiums to decrease by 1.8 percent in
Read More(By Leslie Walker and Dan Gorenstein for NPR) Drugmakers around the globe are bracing for a major shakeup in how
Read More(By Juliette Cubanski and Anthony Damico for Kaiser Family Foundation Published: Jul 26, 2023) The Medicare Part D program provides
Read More(By Rylee Wilson for Becker’s Hospital Review) Virginia made capitation payments for thousands of Medicaid enrollees after their deaths, an
Read More(By Rylee Wilson for Becker’s Hospital Review) Recent studies have uncovered differences between networks, beneficiary characteristics and medications prescribed in
Read More(By Alan Condon for Becker’s Hospital Review) A PatientRightsAdvocate.org report published July 20 found that only 721 (36 percent) of
Read More(By Rylee Wilson for Becker’s Hospital Review) Audits from HHS’ Office of Inspector General published in the first half of
Read More(By Noam N. Levey for KFF Health News) For Emily Boller, it was a $5,000 hospital bill for a simple
Read More(By Rylee Wilson for Becker’s Hospital Review) Medicare Advantage overpayments may be higher than the the Medicare Payment and Advisory
Read More